Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases Grant US-11369620-B2 United States of America 28 Jun 2022
SSEA-4 BINDING MEMBERS Application WO-2021044039-A1 World Intellectual Property Organisation (WIPO) 11 Mar 2021
BIOLOGICAL MARKERS FOR IDENTIFYING IBRUTINIB RESISTANCE IN PATIENTS HAVING MANTLE CELL… Application WO-2016071770-A3 World Intellectual Property Organisation (WIPO) 11 Aug 2016